» Articles » PMID: 34042953

Using Interpretable Deep Learning to Model Cancer Dependencies

Overview
Journal Bioinformatics
Specialty Biology
Date 2021 May 27
PMID 34042953
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Cancer dependencies provide potential drug targets. Unfortunately, dependencies differ among cancers and even individuals. To this end, visible neural networks (VNNs) are promising due to robust performance and the interpretability required for the biomedical field.

Results: We design Biological visible neural network (BioVNN) using pathway knowledge to predict cancer dependencies. Despite having fewer parameters, BioVNN marginally outperforms traditional neural networks (NNs) and converges faster. BioVNN also outperforms an NN based on randomized pathways. More importantly, dependency predictions can be explained by correlating with the neuron output states of relevant pathways, which suggest dependency mechanisms. In feature importance analysis, BioVNN recapitulates known reaction partners and proposes new ones. Such robust and interpretable VNNs may facilitate the understanding of cancer dependency and the development of targeted therapies.

Availability And Implementation: Code and data are available at https://github.com/LichtargeLab/BioVNN.

Supplementary Information: Supplementary data are available at Bioinformatics online.

Citing Articles

SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.

Zangene E, Marashi S, Montazeri H Sci Rep. 2023; 13(1):15763.

PMID: 37737478 PMC: 10516981. DOI: 10.1038/s41598-023-42992-4.


Knowledge graph aids comprehensive explanation of drug and chemical toxicity.

Hao Y, Romano J, Moore J CPT Pharmacometrics Syst Pharmacol. 2023; 12(8):1072-1079.

PMID: 37475158 PMC: 10431039. DOI: 10.1002/psp4.12975.


Network Biology-Inspired Machine Learning Features Predict Cancer Gene Targets and Reveal Target Coordinating Mechanisms.

Weiskittel T, Cao A, Meng-Lin K, Lehmann Z, Feng B, Correia C Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242535 PMC: 10223789. DOI: 10.3390/ph16050752.


Predicting genetic interactions, cell line dependencies and drug sensitivities with variational graph auto-encoder.

Gervits A, Sharan R Front Bioinform. 2022; 2:1025783.

PMID: 36530386 PMC: 9755598. DOI: 10.3389/fbinf.2022.1025783.


Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cells.

Samal B, Loers J, Vermeirssen V, De Preter K Front Bioinform. 2022; 2:1036963.

PMID: 36466148 PMC: 9714662. DOI: 10.3389/fbinf.2022.1036963.